OQRO

Feed News

Explore

Insider trades Fund moves Congressional trades Federal contracts Screener

Yours

Watchlist Alerts Saved Ask Claude or ChatGPT

Create a free account Sign in

OQRO

Search/

Loading…

Director exercised or converted 51K GDRX derivative securities | OQRO

Home
Insider trades
Goodrx Holdings
Director exercised or converted 51K GDRX derivative securities

Insider trades

Insider trade

Director exercised or converted 51K GDRX derivative securities

Traded Apr 15, 2026 · Filed Apr 15, 2026

Goodrx HoldingsGDRX

51K
Derivative units

Why it stands out

Derivative exercise or conversion — not an open-market buy.

Written from the filing's own figures. OQRO describes what was reported and never tells you what to buy or sell

View the official recordSEC Form 4 — Statement of Changes in Beneficial Ownership

All the details

Dates, kept separate

Transaction date: Apr 15, 2026
Reporting period: Not applicable
Filed with the SEC: Apr 15, 2026

DirectorOption exercise

Context

Classification

option exercise

Code M — exercise or conversion of a derivative security

Planned / mechanical clue

Footnote references vesting of compensation awards

Only flagged when a footnote says so; never inferred

Source receipt

Record ID: 0001809519-26-000074

Ask Claude or ChatGPT about these filings. Connect OQRO in a minute, then ask things like “which insiders bought this week?”

Filed / recorded

Apr 15, 2026, 9:54 PM UTC

Added to OQRO

Oct 7, 2026, 5:51 AM UTC

Parser

form4-xml-v2

Data quality

Verified: identifiers matched exactly

Issuer

GoodRx Holdings, Inc.

Issuer CIK

1809519

Ticker

GDRX

Reporting person

Wendy Lynn Barnes

Relationship

Director, Officer

Officer title

See Remarks

Security

Restricted Stock Unit

Table

Derivative (Table II)

Transaction date

Apr 15, 2026

Transaction code

Shares / units

51,177

Price per share

$0.00

Acquired / disposed

Disposed (D)

Shares owned after

153,531

Ownership form

Direct

Amendment

Footnotes from the filing

Each restricted stock unit represents a contingent right to receive one share of Class A common stock.
The restricted stock unit award will vest as to 50% of the underlying shares on January 15, 2026 with the remaining 50% to vest in approximately equal quarterly installments thereafter for 4 quarters.